Myopia - 71 Studies Found
Completed |
: Evaluation of the Prophylactic Use of Mitomycin C 0.02% to Inhibit Haze Formation After Photorefractive Keratectomy for High Myopia: 15 x 30 Seconds : High Myopia : 2007-11-26 : Drug: PRK and a single intraoperative topical application of mitomycin C 0.02% for 15 seconds Mitomycin |
Completed |
: Study of Theories About Myopia Progression (STAMP) : Myopia : 2006-06-07 :
|
Recruiting |
: The Relationship Between Structure and Visual Function in Myopia Foveoschisis : High Myopia : 2016-09-04 : Procedure: macular buckling surgery Participants with high myopia foveoschisis are scheduled to macular |
Enrolling by invitation |
: Time Outdoors as an Intervention for Myopia in Children : Myopia : 2016-11-21 :
|
Recruiting |
: Effect of Orthokeratology Versus Spectacles on Myopia Progression in Chinese Children: A Crossover Trial : Myopia : 2014-06-29 :
|
Recruiting |
: Genomewide Screening of Pathological Myopia : Pathological Myopia : 2005-09-09 |
Recruiting |
: Early Vitrectomy for Macular Tractional Maculopathy : Myopia, Degenerative : 2010-04-30 : Procedure: Early vitrectomy Triamcinolone acetonide assisted pars plana vitrectomy with Indocyanine gree |
Completed |
: Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia : Myopia, Degenerative : 2013-07-10 :
|
Completed |
: Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia :
: 2011-08-22 : Drug: Combretastatin A-4 Phosphate Combretastatin A-4 Phosphate is administered on Day 0 and Day 7 (+/- |
Completed |
: Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen : Choroidal Neovascularisation : 2009-12-21 : Drug: ranibizumab 0.5mg |